Weight Loss Injections in Provo: Comparing Semaglutide, Tirzepatide, and Retatrutide

I get some version of this question almost every day in my Provo clinic: "Which one is right for me, semaglutide, tirzepatide, or retatrutide?" It's a fair question, and an important one. These medications aren't interchangeable, and the "best" option depends on your biology, your goals, and what your body has responded to in the past.

I want to walk you through what I tell my own patients, without the marketing spin you'll find on a lot of weight loss websites.

How These Medications Work

All three of these injections target the hormonal pathways that control hunger, fullness, and metabolism, but they don't all do it the same way.

Semaglutide is a GLP-1 receptor agonist. It mimics a hormone your gut naturally releases after eating, which helps you feel full sooner and longer, reducing the mental noise around food. For many of my Utah Valley patients, this is where we start: it's well studied, predictable, and gives us a clear picture of how your body responds to GLP-1 therapy.

Side effects: The most common side effects are nausea, mild heartburn, and changes in bowel habits, especially during the first few weeks. Most patients find these ease as we slowly titrate the dose.

Tirzepatide works on two pathways instead of one, GLP-1 and GIP. That second pathway plays a role in insulin sensitivity and fat metabolism. In my experience, patients who plateau on semaglutide, or who have more complex metabolic patterns like insulin resistance, often respond well when we transition to tirzepatide.

Side effects: Tirzepatide can cause similar gastrointestinal effects, nausea, reduced appetite, and occasional fatigue, though many patients tell me they tolerate it slightly better than semaglutide. We monitor closely as we adjust your dose.

Retatrutide is the newest of the three, and it adds a third pathway, glucagon receptor activity, on top of GLP-1 and GIP. Early data is promising for patients looking for more significant metabolic support, but because it's newer and is still awaiting FDA clearance, we're more conservative and selective about who's a good candidate.

Side effects: Reported side effects mirror the other two, nausea and digestive changes being most common, but because long-term data is still limited, we watch these patients more closely during treatment.

Why I Don't Start Everyone on the Same Medication

I know it's tempting to want "the strongest one." But stronger isn't always better, especially in the first few months. My approach is conservative dosing, aiming for about 1 to 1.5 pounds of weight loss per week rather than pushing for the fastest number on the scale. Rapid loss increases the risk of muscle loss, nutrient gaps, and rebound weight gain once you stop.

That's also why I use InBody body composition scans at baseline and throughout treatment. A scale tells you a number. An InBody scan tells me whether you're losing fat or losing muscle, and that changes how we adjust your plan.

So Which One Is Right for You?

Here's roughly how I think through it with patients:

• If you're new to GLP-1 therapy, want a well-established starting point, or have mild to moderate appetite-related weight challenges, semaglutide is often our first step.
• If you've plateaued, have insulin resistance, or need a bit more metabolic support, tirzepatide may be the better fit.
• If you have more significant weight loss goals and meet the clinical criteria after evaluation, retatrutide may be worth discussing, with closer monitoring given how new it is.

None of this is one-size-fits-all. Your labs, your health history, and how your body responds in the first few weeks all shape the plan.

What to Expect at Avara Medical

Every patient starts with a full evaluation, not just a prescription. We look at your history, run labs, and use InBody scans to set a real baseline. From there, we monitor closely with monthly check ins, adjust dosing as needed, and provide guidance on nutrition and lifestyle changes that help the results last, on the medication and after.

If you've been researching semaglutide, tirzepatide, or retatrutide and aren't sure which direction makes sense for you, and want a provider to take this journey with you, that's exactly the conversation I want to have with you. Give our Provo office a call at (801) 999-8356, and let's figure out the right path together.